Meta-analysis of cytokines and chemokines in suicidality: Distinguishing suicidal versus nonsuicidal patients

Biological Psychiatry

Volumn 78, Issue 1, 2015, Pages 28-37

  Black, Carmen ^a   Miller, Brian J ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Chemokines; Cytokines; Depression; Inflammation; Meta analysis; Suicide

Indexed keywords

CHEMOKINE; CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; IL6R PROTEIN, HUMAN; IL8 PROTEIN, HUMAN; INTERLEUKIN 6 RECEPTOR;

ARTICLE; BLOOD ANALYSIS; BRAIN LEVEL; CEREBROSPINAL FLUID ANALYSIS; CYTOKINE PRODUCTION; DEPRESSION; HUMAN; INFLAMMATION; META ANALYSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SUICIDAL BEHAVIOR; ADOLESCENT; ADULT; BLOOD; BRAIN; CEREBROSPINAL FLUID; COMPLICATION; FEMALE; MALE; MENTAL DISEASE; METABOLISM; MIDDLE AGED; SUICIDE;

ADOLESCENT; ADULT; BRAIN; CHEMOKINES; CYTOKINES; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-1BETA; INTERLEUKIN-8; MALE; MENTAL DISORDERS; MIDDLE AGED; RECEPTORS, INTERLEUKIN-6; SUICIDE;

EID: 84935021547     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2014.10.014     Document Type: Article

References (47)

1. Dowlati Y, Herrmann N, Swardfater W, Liu H, Sham L, Reim E, Lanctot KL (2010): A meta-analysis of cytokines in major depression. Biol Psychiatry 67:446-457.
2. Miller BJ, Buckley P, Seabolt W, Mellor A, Kirkpatrick B (2011): Meta-analysis of cytokine alterations in schizophrenia: Clinical status and antipsychotic effects. Biol Psychiatry 70:663-671.
3. Munkholm K, Braüner JV, Kessing LV, Vinberg M (2013): Cytokines in bipolar disorder vs.healthy control subjects: A systematic review and meta-analysis. J Psychiatr Res 47:1119-1133.
4. Crews FT, Bechara R, Brown LA, Guidot DM, Mandrekar P, Oak S, et al. (2006): Cytokines and alcohol. Alcohol Clin Exp Res 30:720-730.
5. Díaz-Marsá M, Macdowell KS, Guemes I, Rubio V, Carrasco JL, Leza JC (2012): Activation of the cholinergic anti-inflammatory system in peripheral blood mononuclear cells from patients with borderline personality disorder. J Psychiatr Res 46:1610-1617.
6. MacDowell KS, Díaz-Marsá M, Güemes I, Rodríguez A, Leza JC, Carrasco JL (2013): Inflammatory activation and cholinergic anti-inflammatory system in eating disorders. Brain Behav Immun 32:33-39.
7. Lindqvist D, Wolkowitz OM, Mellon S, Yehuda R, Flory JD, Henn-Haase C, et al. (2014): Proinflammatory milieu in combat related PTSD is independent of depression and early life stress [published online ahead of print Jun. 12]. Brain Behav Immun.
8. Stuart MJ, Baune BT (2014): Chemokines and chemokine receptors in mood disorders, schizophrenia, and cognitive impairment: A systematic review of biomarker studies. Neurosci Biobehav Rev 42:93-115.
9. Baumeister D, Russell A, Pariante CM, Mondelli V (2014): Inflammatory biomarker profiles of mental disorders and their relation to clinical, social and lifestyle factors. Soc Psychiatry Psychiatr Epidemiol 49:841-849.
10. Tidemalm D, Långström N, Lichtenstein P, Runeson B (2008): Risk of suicide after suicide attempt according to coexisting psychiatric disorder: Swedish cohort study with long term follow-up. BMJ 337:a2205.
11. Jones KA, Thomsen C (2013): The role of innate immune system in psychiatric disorders. Mol Cell Neurosci 53:52-62.
12. Serafini G, Pompili M, Elena Seretti M, Stefani H, Palermo M, Coryell W, Girardi P (2013): The role of inflammatory cytokines in suicidal behavior: A systematic review. Eur Neuropsychopharmacol 23:1672-1686.
13. Bay-Richter C, Linderholm KR, Lim CK, Samuelsson M, Träskman-Bendz L, Guillemin GJ, et al. (2014): A role for inflammatory metabolites as modulators of the glutamate N-methyl-d-aspartate receptor in depression and suicidality [published online ahead of print Aug. 12]. Brain Behav Immun.
14. Gabbay V, Klein RG, Guttman LE, Babb JS, Alonso CM, Nishawala M, et al. (2009): A preliminary study of cytokines in suicidal and non-suicidal adolescents with major depression. J Child Adolesc Psycho-pharmacol 19:423-430.
15. Grassi-Oliveira R, Brieztke E, Teixeira A, Pezzi JC, Zanini M, Lopes RP, Bauer ME (2012): Peripheral chemokine levels in women with recurrent major depression with suicidal ideation. Rev Bras Psiquiatr 34:71-75.
16. Huang T, Lee C (2007): T-helper 1/T-helper 2 cytokine imbalance and clinical phenotypes of acute-phase major depression. Psychiatry Clin Neurosci 61:415-420.
17. Isung J, Aeinehband S, Mobarrez F, Mårtensson B, Nordström P, Asberg M, et al. (2012): Low vascular endothelial growth factor and interleukin-8 in cerebrospinal fluid of suicide attempters. Transl Psychiatry 2:e196.
18. Isung J, Mobarrez F, Nordström P, Asberg M, Jokinen J (2012): Low plasma vascular endothelial growth factor (VEGF) associated with completed suicide. World J Biol Psychiatry 13:468-473.
19. Janelidze S, Mattei D, Westrin Å, Träskman-Bendz L, Brundin L (2011): Cytokine levels in the blood may distinguish suicide attempters from depressed patients. Brain Behav Immun 25:335-339.
20. Janelidze S, Ventorp F, Erhardt S, Hansson O, Minthon L, Flax J, et al. (2013): Altered chemokine levels in the cerebrospinal fluid and plasma of suicide attempters. Psychoneuroendocrinology 38:853-862.
21. Karlovic D, Serretti A, Vrkc N, Martinac M, Marcinko D (2012): Serum concentrations of CRP, IL-6, TNF - A and cortisol in major depressive disorder with melancholic or atypical feature. Psychiatry Res 198:74-80.
22. Kim YK, Lee SW, Kim SH, Shim SH, Han SW, Choi SH, Lee BH (2008): Differences in cytokines between non-suicidal patients and suicidal patients in major depression. Prog Neuropsychopharmacol Biol Psychiatry 32:356-361.
23. Lee HY, Kim YK (2010): Transforming growth factor-|51 and major depressive disorder with and without attempted suicide: Preliminary study. Psychiatry Res 178:92-96.
24. Li Z, Qi D, Chen J, Zhang C, Yi Z, Yuan C, et al. (2013): Venlafaxine nhibits the upregulation of plasma tumor necrosis factor-alpha (TNF-a) in the Chinese patients with major depressive disorder: A prospective longitudinal study. Psychoneuroendocrinology 38:107-114.
25. Lindqvist D, Janelidze S, Hagell P, Erhardt S, Samuelsson M, Minthon L, et al. (2009): Interleukin-6 is elevated in the cerebrospinal fluid of suicide attempters and related to symptom severity. Biol Psychiatry 66:287-292.
26. Lindqvist D, Janelidze S, Erhardt S, Träskman-Bendz L, Engström G, Brundin L (2011): CSF biomarkers in suicide attempters - A principal component analysis. Acta Psychiatr Scand 124:52-61.
27. Mendlovic S, Mozes E, Eilat E, Doron A, Lereya J, Zakuth V, Spirer Z (1999): Immune activation in non-treated suicidal major depression. Immunol Lett 67:105-108.
28. Monfrim X, Gazal M, De Leon PB, Quevedo L, Souza LD, Jansen K, et al. (2014): Immune dysfunction in bipolar disorder and suicide risk: Is there an association between peripheral corticotropin-releasing hormone and interleukin-1 p? Bipolar Disord 16:741-747.
29. Nassberger L, Traskman-Bendz L (1993): Increased soluble nterleukin-2 receptor concentrations in suicide attempters. Acta Psychiatr Scand 88:48-52.
30. O'Donovan A, Rush G, Hoatam G, Hughes BM, McCrohan A, Kelleher C, et al. (2013): Suicidal ideation is associated with elevated inflammation in patients with major depressive disorder. Depress Anxiety 30:307-314.
31. Pandey GN, Rizavi HS, Ren X, Fareed J, Hoppensteadt DA, Roberts RC, et al. (2012): Proinflammatory cytokines in the prefrontal cortex of teenage suicide victims. J Psychiatr Res 46:57-63.
32. Rothenhäusler HB, Stepan A, Kapfhammer HP (2006): Soluble inter-leukin 2 receptor levels, temperament and character in formerly depressed suicide attempters compared with normal controls. Suicide Life Threat Behav 36:455-466.
33. Tonelli LH, Stiller J, Rujescu D, Giegling I, Schneider B, Maurer K, et al. (2008): Elevated cytokine expression in the orbitofrontal cortex of victims of suicide. Acta Psychiatr Scand 117:198-206.
34. Vargas HO, Nunes SO, Pizzo De Castro M, Bortolasci CC, Sabbatin Barbosa D, Kaminami Morimoto H, et al. (2013): Oxidative stress and lowered total antioxidant status are associated with a history of suicide attempts. J Affect Disord 25:923-930.
35. Der Simonian R, Laird N (1986): Meta-analysis in clinical trials. Controlled Clin Trials 7:177-188.
36. Hunter J, Schmidt F (2000): Fixed effects vs.random effects metaanalysis models: Implications for cumulative research knowledge. International Journal of Selection and Assessment 8:275-292.
37. Cochran WB (1950): The comparison of percentages in matched samples. Biometrika 37:256-266.
38. Song F, Sheldon TA, Sutton AJ, Abrams KR, Jones DR (2001): Methods for exploring heterogeneity in meta-analysis. Eval Health Prof 24:126-151.
39. Higgins JPT, Green S, editors (2011): Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. Updated March 2011. 9.7. Sensitivity analyses. The Cochrane Collaboration, 2011. Available at: www.cochrane-handbook.org. Accessed September 2014.
40. Sterne JAC, Egger M (2001): Funnel plots for detecting bias in meta-analysis: Guidelines on choice of axis. J Clin Epidemiol 54:1046-1055.
41. Egger M, Davey Smith G, Schneider M, Minder C (1997): Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629-634.
42. StataCorp (2007): Stata Statistical Software: Release 10. College Station, TX: StataCorp LP.
43. O'Connor M, Bower JE, Cho HJ, Creswell JD, Dimitrov S, Hamby ME, et al. (2009): To assess, to control, to exclude: Effects of biobehavioral factors on circulating inflammatory markers. Brain Behav Immun 23:887-897.
44. Sullivan KE, Cutilli J, Piliero LM, Ghavimi-Alagha D, Starr SE, Campbell DE, Douglas SD (2000): Measurement of cytokine secretion, intracellular protein expression, and mRNA in resting and stimulated peripheral blood mononuclear cells. Clin Diagn Lab Immunol 7:920-924.
45. Scheller J, Chalaris A, Schmidt-Arras D, Rose-John S (2011): The pro- and anti-inflammatory properties of the cytokine interleukin-6. Bio-chim Biophys Acta 1813:878-888.
46. Nordentoft M, Mortensen P, Pedersen C (2011): Absolute risk of suicide after first hospital contact in mental disorder. Arch Gen Psychiatry 68:1058-1064.
47. Dieperink E, Willenbring M, Ho SB (2000): Neuropsychiatric symptoms associated with hepatitis C and interferon alpha: A review. Am J Psychiatry 157:867-876.